SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-569377
Filing Date
2016-04-29
Accepted
2016-04-29 16:21:23
Documents
4
Period of Report
2016-06-06
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d81688ddef14a.htm DEF 14A 411911
2 GRAPHIC g81688g21j94.jpg GRAPHIC 24713
3 GRAPHIC g81688g30v63.jpg GRAPHIC 67893
4 GRAPHIC g81688g91x42.jpg GRAPHIC 6375
  Complete submission text file 0001193125-16-569377.txt   549684
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33057 | Film No.: 161606906
SIC: 2834 Pharmaceutical Preparations